Investor FAQ What does Bioscrypt do? Bioscrypt is an enterprise access control solution provider, enabling the unification of physical and logical access through its Door to Desktop® products. Bioscrypt’s hardware and software solutions deliver strong authentication processes to facilities, equipment, IT networks and computer applications and allow organizations to administer unified identity policies across the enterprise. Building on its proven expertise in biometric technology and its unique multi-factor authentication platform, Bioscrypt integrates all major secure authentication protocols, transforming how organizations are bridging the gap between physical and logical access to create secure working environments. How does Bioscrypt generate revenue? In the physical access market, Bioscrypt generates revenues (approx. 90% of current corporate revenues) through the sale of its multi-factor authentication readers and its OEM module that feature proprietary fingerprint matching or 3D face recognition technology. Bioscrypt also develops, markets and sells software for logical access control. This solution can be licensed to corporate enterprises to facilitate strong, convenient access control rights and administration across the enterprise, as well as to computer OEM’s who can incorporate the technology into their hardware at point of manufacture. Who are Bioscrypt's major competitors? Bioscrypt has a range of technology offerings to address physical and logical access. Bioscrypt’s physical access products are sold around the world, through a distribution channel and competes with other manufacturers of fingerprint and face biometric physical access products such as Crossmatch and SAGEM Morpho. Bioscrypt also develops, markets and sells a logical access solution. With functionality including Single Sign On and network log on, this product is competitive with products from Imprivata, Passlogix and ActivIdentity among others Among Bioscrypt’s competitive advantages is its range of products for physical access control, the VeriSeries and VisionAccess readers that support multi-factor authentication at the facility, and software solution for logical access control, VeriSoft Single Sign On, for Multi-Factor authentication to the network, that combine to offer organizations Door to Desktop® access control solutions – a unique offering in the market place. Bioscrypt also develops fingerprint and 3D face biometric algorithms that are integrated within its access control product lines, further extending its differentiation in the market. Where does Bioscrypt trade? Bioscrypt shares trade on the Toronto Stock Exchange under the ticker symbol BYT. How many Bioscrypt shares are issued and outstanding? Bioscrypt has approximately 80 million common shares issued and outstanding, as of March 15, 2007. Who are the major shareholders of Bioscrypt? Bioscrypt is widely held predominantly with retail shareholders. Approx. 35% is held by major shareholders including management, and institutional investors. Where can I find stock price history and historical stock charts for Bioscrypt? See our Investors section for daily stock prices, bid/ask information, the 52 week trading range, average volume and daily volume information. Can I buy or sell stock directly through Bioscrypt? We do not currently offer a direct share purchase program (DSPP). You may buy and sell Bioscrypt shares through a stockbroker, bank, or generally, through a financial institution that provides brokerage services. Who is Bioscrypt’s transfer agent? Our transfer agent is Computershare Investor Services How do I change my address and other information, or to obtain information on my shareholder account? All such requests should be made through our transfer agent, Computershare Investor Services. Please contact them in writing at:
100 University Avenue, 11th Floor
Toronto, ON M5J 2Y1 Telephone:
North America: 1-800-834-9814
International: 1-416-981-9633
Facsimile: (416)-981-9507 When does Bioscrypt’s fiscal year end? Our fiscal year ends on December 31. When do you announce your financial results? We usually announce our financial results in May for first quarter, August for second quarter, October for third quarter, and February for fourth quarter and year-end results. When is your next earnings announcement? Please see our Investor Events page for information on the next earnings announcement How many employees does Bioscrypt have? Bioscrypt has approximately 100 employees as of December 31, 2006. Why are there so few press releases about customer contracts? Bioscrypt markets its products through an international distribution channel of leading security providers. While this is an effective method of deploying our technology worldwide, it also means that Bioscrypt rarely has contact with the end client. This makes it very difficult for the Company to prepare effective and timely press releases. Additionally, many clients view their security system choice as being something they prefer to keep low profile. For these reasons, the Company will often present recaps of installations in our quarterly results about deals that are otherwise not material or appropriate to otherwise press release. Where can I obtain additional information about Bioscrypt? For additional information not found on this Web site or to request printed documents, please contact . When did Bioscrypt become a public company? Bioscrypt (formerly Mytec Technologies Inc.) became a public company on the Toronto Stock Exchange in 1988. The company changed its name to Bioscrypt Inc. in April 2001 upon the completed acquisition of Biometric Identification, Inc. (a private California-based biometrics company).
|
